Back to Journals » International Journal of Nephrology and Renovascular Disease » Volume 9

The cost-utility of treating anemia with continuous erythropoietin receptor activator or Epoetin versus routine blood transfusions among chronic hemodialysis patients

Total article views   HTML views PDF downloads Totals
12,628 Dovepress* 10,587+ 2,148 12,735
PubMed Central* 2,041 432 2,473
Totals 12,628 2,580 15,208
*Since 24 February 2016
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 1 1

View citations on PubMed Central and Google Scholar